Personalised medicine

Deadline for hypoxic tumors

Moving personalized medicine from promise to practice. Siemens Healthcare announces the early study findings of a new imaging biomarker for hypoxic tumors. This clinically problematic cells tend to be less responsive to standard treatment regimens. A probe that measures hypoxia could prove quite a useful tool for oncologists.

Photo

Personalise healthcare!

The Old Dominion University in Virginia and Regensburg University Medical Center in Germany are jointly organizing an international conference to discuss recent advances and strategic needs in personalised healthcare (pHealth) care and to foster collaboration between industry and academia.

Photo

A scales to have faith in

The seca 959, a chair scale, has been designed by seca gmbh & co. kg, Hamburg, Germany, with input from experts, to accommodate patients with mobility or other problems. It is not only easy for patients and nurses to use, but, as the firm explains, `… practically eliminates body contact, which patients of Islamic faith in particular find unpleasant and try to avoid.´

Photo

Are New Techniques Needed in Modern Sonography?

Breast cancer is the most frequently occurring malignant tumour worldwide. Of the more than one million newly diagnosed cases each year, the incidence among women in Germany alone is more than 50,000. That means that every tenth woman is stricken by breast cancer at some point in her life. It numbers among the most frequent causes of death by cancer 1,2,3 , with the average age of onset being…

3 show more articles
Subscribe to Newsletter